Blue Parachute Group
Lorelei Anderson is a seasoned professional in clinical operations, currently serving as Vice President of Clinical Operations at Blue Parachute Group since April 2025. Previously, Lorelei held the position of Director of Clinical Operations at Astellas Pharma US, overseeing Early Development Cell and Gene Therapy programs, with a focus on strategic planning, budget management, and staff mentorship. At Kite Pharma, leadership capabilities were demonstrated through the implementation of operational improvements and clinical trial processes. During a lengthy tenure at Pfizer, Lorelei excelled in various roles including Clinical Study Team Lead and Director of Study Management, recognized for exceptional project management and innovative process development. Lorelei began a career in clinical research at Kforce Global Solutions, Inc., as a Lead Clinical Research Site Manager.
This person is not in any teams
This person is not in any offices
Blue Parachute Group
Have you outsourced your pivotal clinical trial to a CRO and think your study data quality or Trial Master File completeness might be in jeopardy? Do you seek an independent team to review your current data and identify potential risks to your program? Do you think your trial master file (TMF) would survive a Regulatory or Due Diligence audit? The Blue Parachute group has your back! We will listen to your program's pain points and pitfalls and propose ways we can help de-risk your program. Over our careers, we have partnered with many pharmaceutical and biotech companies to make sure their critical programs stay on track. The Blue Parachute group is comprised of clinical and industry individuals: many with over 25 years of experience. We have offices in Ann Arbor, Michigan and are currently expanding our team!